Overview

Safety, Tolerability and Pharmacokinetics of BIBW 2948 BS in Healthy Male Volunteers

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to investigate safety, tolerability, and pharmacokinetics of BIBW 2948 BS
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim